Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Harvard Business School
Dow
Moodys
Express Scripts

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

SANTYL Drug Profile

See Plans and Pricing

« Back to Dashboard

Pharmacology for SANTYL
Ingredient-typeCollagenases

US Patents for SANTYL

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial Advance Biofactures Corporation (Lynbrook, NY) 2039-02-26 RX search
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial Musculoskeletal Transplant Foundation (Edison, NJ) 2039-02-26 RX search
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial Musculoskeletal Transplant Foundation (Edison, NJ) 2039-02-26 RX search
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial 2013-12-10 RX search
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial 2030-01-22 RX search
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Start Trial LifeCell Corporation (Branchburg, NJ) 2032-04-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Supplementary Protection Certificates for SANTYL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C300091 Netherlands   Start Trial PRODUCT NAME: ANAKINRA; REGISTRATION NO/DATE: EU/1/02/203/001-004 20020308
CA 2017 00067 Denmark   Start Trial PRODUCT NAME: DEOXYCHOLSYRE NATRIUMSALT; NAT. REG. NO/DATE: 59040 20170703; FIRST REG. NO/DATE: IS IS/1/16/071/01 20160729
2002C/023 Belgium   Start Trial PRODUCT NAME: ANAKINRA; REGISTRATION NO/DATE: EU/1/02/203/001 20020311
92273 Luxembourg   Start Trial PRODUCT NAME: MICROPLASMIN
2010/021 Ireland   Start Trial PRODUCT NAME: AGALSIDASE ALFA; NAT REGISTRATION NO/DATE: EU/1/01/188/001-003 20010803; FIRST REGISTRATION NO/DATE: EU/1/01/189/001 03/08/2001 EUROPEAN UNION EU/1/01/188/001-003 03/08/2001 EUROPEAN UNION EU/1/01/189/001 20010803
SZ 23/2002 Austria   Start Trial PRODUCT NAME: ANAKINRA
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Colorcon
Johnson and Johnson
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.